01Population
Every forecast starts with the right patients.
We turn incidence and prevalence into the population that matters for your decision. Diagnosis, stage, biomarker, eligibility and line of therapy, each step sourced and open to challenge.
Commercial analytics for biotech and pharma
We size the patients, build the forecast and map the patient journey, so you can see where an asset goes next and what it is worth when it gets there.
01Population
We turn incidence and prevalence into the population that matters for your decision. Diagnosis, stage, biomarker, eligibility and line of therapy, each step sourced and open to challenge.
02Forecast
Patient-based demand and revenue forecasts with every assumption on the table. Base, upside and downside, and the conditions that would make each one true.
03Journey
We reconstruct real patient journeys from event data, find the delays and missed handoffs, and turn them into exception reports your operations team acts on.
04Decision
Indications compared on the same patients, the same competitors and the same assumptions. A clear brief on where to go next, and what would change the answer.
Team experience
Before NextIndication, our team worked in oncology commercial insights and patient-services analytics at top-10 global pharma companies.
oncology projects with country-level epidemiology and patient-flow models
oncology assets with patient-based forecasts
priority projects run on one standardized scenario approach
match to official sources on a one-billion-record data pipeline
Team experience before NextIndication. Project counts overlap and are not added together.
Epidemiology, forecasting and asset assessment across solid tumours and haematological cancers, from literature review to the executive presentation.
Product ownership of patient process-mining tools and an automated exception report that operations teams use every cycle.
Doctoral research in computational genomics with peer-reviewed publications, plus quantitative research on billion-record datasets.
What we do
Core practice
Epidemiology, patient flows and patient-based forecasts with scenarios and sensitivity. The centre of every asset decision.
Our namesake
Compare indications, assets and deals on one consistent set of patients, competitors and assumptions.
Pipelines mapped by indication, mechanism, stage and setting, with updates focused on what changes your decision.
Core practice
Process mining for patient-support programs. See how cases really move, where they wait and what happens after you act.
From forecast to risk-adjusted value, milestones and royalties, so the science and the numbers stay linked.
Reporting pipelines, monitoring and scenario tools that replace manual preparation and keep running after we leave.
Doctoral training in computational genomics means we read the evidence behind the asset, not only the market around it.
Live model
A simplified version of how we build: patients first, every driver visible. Try it.
Illustrative model with synthetic assumptions. It is not a forecast for any real product.
Patient journeys
Most reports show how many patients sit in each status. We show how they move, where they wait and which ones need a person to look today.
Simulated cases for illustration.
Rebuild every journey from recorded events and timestamps. Common routes, detours, repeats and the ones that never finish.
Explicit review rules with time thresholds and exclusions, delivered as a list your team can act on inside its existing workflow.
Track which flagged cases were reviewed and what happened next, with clear denominators and honest observation windows.
Where to start
Which indication should come next?
How big is this, really?
Can we trust this model?
Where are patients getting stuck?
What just changed?
What is it worth?
How we work
We start from the decision you need to make, not from the data you happen to have.
Patients first. Every assumption is explicit, sourced and editable.
Scenarios and sensitivities show what drives the answer and what would change it.
You keep the model, the sources and the documentation. No black boxes, no lock-in.
Get in touch
Tell us the decision in front of you. We will tell you what it takes to answer it.